Pharmacokinetics and pharmacodynamics of alirocumab in patients with autosomal dominant hypercholesterolemia associated with PCSK9 gain-of-function or ApoB loss-of-function mutations
Event:
ESC Congress 2018
Topic:
Lipid-Lowering Agents
Session:
Innovative drug therapies
